A Study of JNJ-63733657 in Healthy Japanese Participants

NCT03689153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-63733657
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.